Joakim Dillner
Titel
Prof.
Organisation
+4640338126
+46768871126
Joakim [dot] Dillner [at] med [dot] lu [dot] se
Publikationer (hämtat ur Lunds universitets publikationsdatabas)
författare
- 2013
- Absence of Epstein-Barr and Cytomegalovirus Infection in Neuroblastoma Cells by Standard Detection Methodologies.
- High-Throughput Monitoring of Human Papillomavirus Type Distribution
- Human papillomavirus typing in reporting of condyloma.
- Metagenomic sequencing of "HPV-negative" condylomas detects novel putative HPV types.
- Prospective Study of HPV16 Viral Load and Risk of In Situ and Invasive Squamous Cervical Cancer
- Prospective study of genital human papillomaviruses and nonmelanoma skin cancer.
- Pseudovirion-binding and neutralizing antibodies to cutaneous Human Papillomaviruses correlated to presence of HPV DNA in skin.
- Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study.
- Serum antibodies to human papillomavirus (HPV) pseudovirions correlate with natural infection for 13 genital HPV types.
- 2012
- A nested case-control study of intrauterine exposure to persistent organochlorine pollutants and the risk of hypospadias.
- Combined effect of low-penetrant SNPs on breast cancer risk.
- Decline of the new Swedish variant of Chlamydia trachomatis after introduction of appropriate testing.
- Human Papillomavirus Antibody Reference Reagents for Use in Postvaccination Surveillance Serology
- International collaborative proficiency study of Human Papillomavirus type 16 serology.
- No evidence of enteroviruses in the intestine of patients with type 1 diabetes
- Phylogenetically diverse TT virus viremia among pregnant women
- Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
- Prospective Study of Human Papillomavirus Seropositivity and Risk of Nonmelanoma Skin Cancer
- Randomised health services studies
- The 2010 global proficiency study of Human Papillomavirus genotyping in vaccinology.
- Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity.
- 2011
- A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNP.
- Antibodies to merkel cell polyomavirus correlate to presence of viral DNA in the skin.
- Characterization of the complete genomes of Camelus dromedarius papillomavirus types 1 and 2
- Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
- Dietary factors and in situ and invasive cervical cancer risk in the European prospective investigation into cancer and nutrition study
- Genotyping of human papillomavirus in triaging of low-grade cervical cytology.
- High throughput sequencing reveals diversity of human papillomaviruses in cutaneous lesions.
- Human papillomavirus type-specific risk of cervical cancer in a population with high human immunodeficiency virus prevalence: case-control study
- Monitoring of human papillomavirus vaccination.
- Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.
- Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer
- Randomized healthservices study of human papillomavirus-based management of low-grade cytological abnormalities.
- Risk of second cancers after the diagnosis of Merkel cell carcinoma in Scandinavia.
- Seroconversion to islet autoantibodies between early pregnancy and delivery in non-diabetic mothers
- 2010
- A global proficiency study of Human Papillomavirus genotyping.
- A summary of the 25th International Papillomavirus Conference 2009: Vaccines, screening, epidemiology and therapeutics
- Cervical cytology biobanking in Europe
- Ensuring quality in studies linking cancer registries and biobanks
- Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women.
- Induction of Broadly Cross-neutralizing Antisera against Mucosal and Cutaneous Human Papillomayiruses (HPV) by HPV16L1-16L2 Virus-like Particles (RG1-VLP)
- Professor Geo von Krogh Obituary
- Prospective Study of Human Papillomavirus (HPV) Types, HPV Persistence, and Risk of Squamous Cell Carcinoma of the Cervix
- Prospective study of human papillomavirus and risk of cervical adenocarcinoma
- The interface of population-based cancer registries and biobanks in etiological and clinical research - current and future perspectives.
- Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples.
- Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin coated beads.
- 2009
- A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
- A modified general primer PCR system for sensitive detection of multiple types of oncogenic Human Papillomavirus.
- Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies
- EUROCOURSE: towards optimisation of the use of cancer registries for scientific excellence in cancer research in Europe: an FP7 ERA-net project
- EUROGIN 2008 roadmap on cervical cancer prevention
- Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
- Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: A nested case-referent study
- Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
- Introduction of human papillomavirus (HPV) vaccination in Sweden
- Is Smoking an Independent Risk Factor for Invasive Cervical Cancer? A Nested Case-Control Study Within Nordic Biobanks
- Male Circumcision and Serologically Determined Human Papillomavirus Infection in a Birth Cohort
- Maternal smoking during pregnancy and testicular cancer in the sons: A nested case-control study and a meta-analysis
- Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus
- No Risk of Maternal EBV Infection for Childhood Leukemia.
- Penile cancer: epidemiology, pathogenesis and prevention
- Risk of invasive cervical cancer in relation to management of abnormal Pap smear results
- Staphylococcus aureus and Squamous Cell Carcinoma of the Skin.
- The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma.
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16-26 Years
- The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24
- Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate
- Validity of maternal genotypes in DNA from archival pregnancy serum samples.
- 2008
- A randomized trial of basing treatment on human papillomavirus and/or cytology results in low-grade cervical lesion triage
- Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials
- Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers
- Cost-effectiveness of primary cytology and HPV DNA cervical screening
- Cutaneous human papillomavirus 88: Remarkable differences in viral load.
- Differences in transcriptional activity of cutaneous human papillomaviruses.
- Extremely high viral loads of HPV26 and HPV88 in squamous cell carcinomas (SCC) of the nail unit in an HIV-immunosuppressed patient
- Four novel human betapapillomaviruses of species 2 preferentially found in actinic keratosis.
- HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
- High throughput genotyping of oncogenic human papilloma viruses using MALDI-TOF mass spectrometry.
- Human Papillomavirus (HPV) 26 and HPV 88 replicate to extremely high levels in squamous cell carcinomas (SCC) of the nail unit in anHIV-immunosuppressed patient
- Infection with Parvovirus B19 and Herpes viruses in early pregnancy and risk of second trimester miscarriage or very preterm birth
- JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
- Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.
- Maternal smoking during pregnancy, and testicular cancer in the offspring
- Multiplex detection of human herpesviruses from archival specimens by using matrix-assisted laser desorption ionization-time of flight mass spectrometry.
- Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
- Screening-preventable cervical cancer risks: Evidence from a nationwide audit in Sweden
- Seroepidemiology as basis for design of a human papillomavirus vaccination program.
- Seroreactivity to Cutaneous Human Papillomaviruses among Patients with Nonmelanoma Skin Cancer or Benign Skin Lesions.
- Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection
- Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
- 2007
- Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring
- Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study
- Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals
- Assessing Quality and Functionality of DNA from Fresh and Archival Dried Blood Spots and Recommendations for Quality Control Guidelines.
- Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies
- Characterization of two novel cutaneous human papillomaviruses, HPV93 and HPV96.
- Cutaneous Human Papillomaviruses Persist on Healthy Skin.
- Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma
- Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles.
- Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles.
- Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials
- Ethical framework for previously collected biobank samples
- HPV type-specific risks of high-grade CIN during 4 years of follow-up: A population-based prospective study
- Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
- Human papillomavirus subtypes are not uncommon.
- In vivo and in vitro intragenomic rearrangement of TT viruses
- Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer
- Methods for screening and diagnosis
- Multiplex detection of all Herpes viruses from archival specimens using MALDI-TOF Mass spectrometry.
- No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden.
- No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus.
- Nordic biological specimen banks as basis for studies of cancer causes and control - more than 2 million sample donors, 25 million person years and 100 000 prospective cancers
- Population-based study of screening test performance indices of three human papillomavirus DNA tests
- Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection
- Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
- Review of current knowledge on HPV vaccination: An Appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
- Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study.
- Seroprevalences of Human Papillomaviruses, Chlamydia trachomatis and cervical cancer risk: Nested-case control study
- Seroreactivity to cutaneous human Papillomaviruses among patients with non melanoma skin cancer or benign skin lesions.
- Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
- Translational Mini-Review Series on Vaccines: Monitoring of human papillomavirus vaccination.
- 2006
- A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening
- Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies - International collaboration of epidemiological studies of cervical cancer
- Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies.
- Clinical applications of HPV testing: A summary of meta-analyses
- Comparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe
- Detection of adeno-associated virus type 2 genome in cervical carcinoma
- Epidemiology of Kaposi's sarcoma herpesvirus (HHV8) in Vasterbotten county, Sweden
- Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients
- International Standard reagents for harmonization of HPV serology and DNA assays - an update
- Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses
- Results of the first World Health Organization international collaborative study of detection of Human Papillomavirus DNA.
- Serological diagnosis of human polyomavirus infection
- Serological diagnosis of human polyomavirus infection.
- Should donors be allowed to give broad consent to future biobank research?
- Should donors be authorized to give broad consent to future biobank research?
- Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries
- Subtype HPV38bFA125 demonstrates heterogeneity of human papillomavirus type 38.
- Svensk konsensus om vaccination mot cervixcancer. Vaccinprogram bör införas i grundskolan med sikte på att utrota HPV16/18
- 2005
- A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia
- Abstract I: Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles
- Abstract II: No difference in JCV or BKV seroprevalence between colon cancer patients and controls
- Chlamydia trachomatis infection and persistence of human papillomavirus.
- Chlamydial antibodies and risk of prostate cancer
- Clinical utility of HPV-DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence.
- Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence
- Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.
- Comparison of archival plasma and formalin-fixed paraffin-embedded tissue for genotyping in hepatocellular carcinoma.
- Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: Basis for a virus-like particle ELISA
- Heparin-based ELISA reduces background reactivity in virus-like particle-based papillomavirus serology.
- Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.
- Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk
- Maternal human polyomavirus infection and risk of neuroblastoma in the child.
- No Serological Evidence of Association between Prostate Cancer and Infection with Herpes Simplex Virus Type 2 or Human Herpesvirus Type 8: A Nested Case-Control Study.
- Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles.
- Screening for cervixcancer kan vara kostnadseffektiv. Kombinationen cellprov och HPV-test skulle ge ytterligare vinster.
- Toward "serolomics": papillomavirus serology is taking a technologic lead in high-throughput multiplexed antibody analysis.
- 2004
- A population-based study of cervical carcinoma and HPV infection in Latvia.
- An altered immune response to Epstein-Barr virus in multiple sclerosis - A prospective study
- Att förebygga livmoderhalscancer: Gynekologisk cellprovtagning samt vaccination mot Papillomvirus.
- Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.
- Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine?
- HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses
- High Prevalence of Cutaneous Human Papillomavirus DNA on the Top of Skin Tumors but not in "Stripped" Biopsies from the Same Tumors.
- High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
- Human papillomavirus genotypes in cervical cancers in Mozambique.
- Infektioner som kan framkalla cancer.
- Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri
- Malignant epithelial tumors
- Metabolism of 25-hydroxyvitamin D-3 may explain the U-shaped risk curve for prostate cancer
- Re: Have we resolved how to triage equivocal cervical cytology?
- Virologic versus cytologic triage of women with equivocal pap smears: A meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia
- 2003
- Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later.
- Letter to the editor - Reply
- Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11.
- Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring.
- Moderate variation of the oncogenic potential among high-risk human papillomavirus types in gynecologic patients with cervical abnormalities.
- Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study.
- Prövning av HPV-vaccin ger etiskt dilemma. Kan vi låta bli att erbjuda vaccin mot infektion som orsakar cancer?
- Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites.
- Seroepidemiology of the human polyomaviruses.
- Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer.
- Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland.
- Vaccin mot papillomvirus effektivt.
- 2002
- A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma.
- A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas.
- Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.
- Clustering of seropositivities for sexually transmitted infections.
- Danska biobanksutredningen föreslår »avhopps»-register
- Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
- Evaluation of cost-precision rations of different strategies for ELISA measurement of serum antibody levels.
- Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries.
- Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study.
- Laboratory diagnosis of human herpesvirus 8 infection in humans.
- Nya Biobankslagen antagen: Unik chans till förbättring
- Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish Women.
- Preventive human papillomavirus vaccination
- Preventive human papillomavirus vaccination.
- Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia.
- Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes.
- Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom
